首页> 外国专利> Compound, method for inducing de differentiation cell in malignant cells, a method for the treatment of a proliferative all skin in mammals.Method for treatment of primary and secondary disturbance of hyperparathyroidism, pharmaceutical composition and method for treatment of neoplastic diseases

Compound, method for inducing de differentiation cell in malignant cells, a method for the treatment of a proliferative all skin in mammals.Method for treatment of primary and secondary disturbance of hyperparathyroidism, pharmaceutical composition and method for treatment of neoplastic diseases

机译:化合物,在恶性细胞中诱导分化细胞的方法,用于治疗哺乳动物增殖性皮肤的方法。用于治疗甲状旁腺功能亢进的原发和继发性紊乱的方法,药物组合物和治疗肿瘤性疾病的方法

摘要

This invention provides a novel class of vitamin D-related compounds, namely the 1 alpha -hydroxy-19-nor-vitamin D analogs, as well as a general method for their chemical synthesis. The compounds exhibit pronounced activity in arresting the proliferation of undifferentiated cells, including malignant cells, and in inducing their differentiation, and thus represent novel therapeutic agents for the treatment of malignant and other diseases characterized by the proliferative growth of undifferentiated cells. Formulations for therapeutic use and treatment methods are also provided. The 19-nor analogs useful herein are of the general formula IMAGE where X1 and X2 each hydrogen, acyl, alkylisilyl or alkoxyalkyl, and where R is any of the typical side chains known for vitamin D type compounds.
机译:本发明提供了一类新的维生素D相关化合物,即1-α-羟基-19-去甲维生素D类似物,及其化学合成的一般方法。该化合物在阻止包括恶性细胞在内的未分化细胞的增殖以及诱导其分化方面显示出显着的活性,因此代表了用于治疗以未分化细胞的增殖性生长为特征的恶性和其他疾病的新型治疗剂。还提供了用于治疗用途和治疗方法的制剂。可用于本文的19-nor类似物具有通式,其中X 1和X 2各自为氢,酰基,烷基烯丙基或烷氧基烷基,并且其中R为维生素D型化合物已知的任何典型侧链。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号